Mohamed M Shamseldin

Prime-pull immunization of mice with a BcfA-adjuvanted vaccine elicits mucosal immunity and prevents SARS CoV-2 infection and pathology

Gilian Gunsch, K. Oestreich, K. Corps, 2022, bioRxiv.

A highly efficacious live attenuated mumps virus–based SARS-CoV-2 vaccine candidate expressing a six-proline stabilized prefusion spike

A. Kapoor, M. Peeples, Jianrong Li, 2022, Proceedings of the National Academy of Sciences of the United States of America.

Systemic priming and intranasal booster with a BcfA-adjuvanted acellular pertussis vaccine generates CD4+ IL-17+ nasal tissue resident T cells and reduces B. pertussis nasal colonization

Yimin Huang, J. Maynard, S. Quataert, 2023, Frontiers in Immunology.

A next-generation intranasal trivalent MMS vaccine induces durable and broad protection against SARS-CoV-2 variants of concern

M. Peeples, J. Yount, Shan-Lu Liu, 2023, Proceedings of the National Academy of Sciences of the United States of America.

Prime-Pull Immunization of Mice with a BcfA-Adjuvanted Vaccine Elicits Sustained Mucosal Immunity That Prevents SARS-CoV-2 Infection and Pathology.

M. Peeples, Jianrong Li, S. Chaiwatpongsakorn, 2023, Journal of immunology.

Microglia-targeted inhibition of miR-17 via mannose-coated lipid nanoparticles improves pathology and behavior in a mouse model of Alzheimer’s disease

Hazem E. Ghoneim, Shady Z K Estfanous, Asmaa Badr, 2024, Brain, Behavior, and Immunity.

Three SARS-CoV-2 spike protein variants delivered intranasally by measles and mumps vaccines are broadly protective

M. Peeples, P. Boyaka, C. Ye, 2024, Nature communications.

The adjuvant BcfA activates antigen presenting cells through TLR4 and supports TFH and TH1 while attenuating TH2 gene programming

Kaitlin A. Read, Kenneth J. Oestreich, R. Deora, 2024, Frontiers in immunology.